AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Journal of Neurorestoratology Article
Article Link
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Research | Open Access

Negative urgency and negative affect paradigms in patients during cocaine detoxification treatment: Relationship to craving behaviour

Juán J. Vilapriñoa,b, Gabriela Clavela, Mauricio Silvaa, Edgardo O. Alvarezb( ), Silvia G. Rattib
Del Prado Clinic, Study and Research in Neuroscience Center, 5500 Mendoza, Argentine
Epigenesis and Experimental Neuropsicopharmacology Laboratory, Medical Sciences Faculty, Catholic University of Cuyo, campus San Luis, 5700 San Luis, Argentine
Show Author Information

Abstract

Drug addiction is one of the most concerning problems globally. Significant advances have been made in understanding the physiological brain mechanisms underlying addiction to numerous substances, such as alcohol and opioids. Although experimental evidence suggests that addiction to these substances involves common neural structures and pathways, the pathophysiological mechanism underlying addiction to other substances, such as cocaine, remains uncertain. In our study, craving, as a traditional behavioral driving force of drug consumption, was revised and contrasted with alternative behavioral expressions, such as negative and positive affect, which have been shown to complement the complex expression of addictive behavior toward alcohol and other substances, for instance nicotine and opiods. In cocaine addiction, the interaction between craving behavior and the behavioral processes of positive and negative affect is unclear. Thus, we aimed to evaluate these interactions in cocaine consumers in the city of Mendoza, Argentina.

Twenty-seven men and five women were selected after providing informed consent to participate in the detoxifying program of the Psychiatric Clinic Del Prado of the city of Mendoza. Blood samples for cortisol measurement were acquired, and psychometric tests for evaluating positive and negative affect, craving, depression, and impulsivity were performed at the beginning of treatment (t0) and at discharge on day 14 (tF).

Results showed that negative affect and craving behavior decreased at tF. Positive affect showed an inverse relationship with craving at tF. Impulsivity scores improved at the end of treatment; moreover, depression and global clinical impression scores significantly improved. Cortisol blood levels significantly decreased, which suggested that patients were less stressed at tF.

Our results suggest that during cocaine withdrawal, positive and negative affect interact with craving to reduce craving behavior, which lowers the impact of stress on consumption.

Keywords

Negative affectNegative urgencyCocaine craving

References

1

Sturm R, Andreyeva T, Ringel J. Variations in mental health specialty care across metropolitan areas. Psychiatr Serv. 2002;53(6):674. https://doi.org/10.1176/appi.ps.53.6.674.
Crossref Google Scholar
2

Beaglehole R, Bonita R, Alleyne G, et al. NCDs: celebrating success, moving forward. Lancet. 2011;378(9799):1283–1284. https://doi.org/10.1016/S0140-6736(11)61559-6.
Crossref Google Scholar
3
OEA/CICAD. Informe sobre el consumo de drogas en las ame'ricas. OEA/Ser.L/XIV. 2011;6:1–311. ISBN 978-0-8270-6794-3. Website online: https://www.oas.org/ext/DesktopModules/MVC/OASDnnModules/Views/Item/Download.aspx?type=1&id=650&lang=1. Accessed September 3, 2019.
4
UNODC World Drug Report. United Nations publication; 2021. Website online: https://wdr.unodc.org/. [Accessed 10 December 2021].
5

GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204–1222. https://doi.org/10.1016/S0140-6736(20)30925-9.
Crossref Google Scholar
6

Kawa AB, Allain F, Robinson TE, et al. The transition to cocaine addiction: the importance of pharmacokinetics for preclinical models. Psychopharmacology. 2019;236(4):1145–1157. https://doi.org/10.1007/s00213-019-5164-0.
Crossref Google Scholar
7

Panlilio LV, Stull SW, Bertz JW, et al. Beyond abstinence and relapse: cluster analysis of drug-use patterns during treatment as an outcome measure for clinical trials. Psychopharmacology. 2020;237(11):3369–3381. https://doi.org/10.1007/s00213-020-05618-5.
Crossref Google Scholar
8

Jones W. Cocaine use and the breastfeeding mother. Pract Midwife. 2015;18(1):19–22.

Google Scholar
9

Richards JR, Lange RA. Labetalol and cardiovascular consequences of cocaine use. Trends Cardiovasc Med. 2016;26(2):202–203. https://doi.org/10.1016/j.tcm.2015.05.002.
Crossref Google Scholar
10

Bachi KR, Mani V, Jeyachandran D, et al. Vascular disease in cocaine addiction. Atherosclerosis. 2017;262:154–162. https://doi.org/10.1016/j.atherosclerosis.2017.03.019.
Crossref Google Scholar
11

Koob GF. Antireward, compulsivity, and addiction: seminal contributions of Dr. Athina Markou to motivational dysregulation in addiction. Psychopharmacology. 2017;234(9/10):1315–1332. https://doi.org/10.1007/s00213-016-4484-6.
Crossref Google Scholar
12

Kampman KM. The treatment of cocaine use disorder. Sci Adv. 2019;5(10):eaax1532. https://doi.org/10.1126/sciadv.aax1532.
Crossref Google Scholar
13
Waisman M. Cocaina. Aspectos generales. In: Editorial P, ed. Adicciones: Uso de sustancias psicoactivas y presentaciones clínicas adictivas. Madrid, Spain: AXON Librería; 2017:3–20 [Chapter 1].
14

López DA, Becoña IE. El craving en personas dependientes de la cocaína. An Psicol. 2006;22(2):205–211.

Google Scholar
15

Nicolas C, Zlebnik NE, Farokhnia M, et al. Sex differences in opioid and psychostimulant craving and relapse: a critical review. Pharmacol Rev. 2022;74(1):119–140. https://doi.org/10.1124/pharmrev.121.000367.
Crossref Google Scholar
16

Miller NS, Goldsmith RJ. Craving for alcohol and drugs in animals and humans: biology and behavior. J Addict Dis. 2001;20(3):87–104. https://doi.org/10.1300/J069v20n03_08.
Crossref Google Scholar
17

Ehlers CL, Gilder DA, Gizer IR, et al. Indexing the 'dark side of addiction': substance-induced affective symptoms and alcohol use disorders. Addiction. 2019;114(1):139–149. https://doi.org/10.1111/add.14431.
Crossref Google Scholar
18
Vilapriño JJ. Comorbilidad de difícil manejo: depresión mayor y trastorno por consumo de sustancias [Chapter 11]. In: Vilapriño M, Vilapriño JJ, Motuca M, eds. Depresión de difícil manejo. Moreno, Argentina: Editorial Polemos; 2018: 295–308. Bs. As. ISBN 978-987-649-9876-3.
19

Shurman J, Koob GF, Gutstein HB. Opioids, pain, the brain, and hyperkatifeia: a framework for the rational use of opioids for pain. Pain Med. 2010;11(7):1092–1098. https://doi.org/10.1111/j.1526-4637.2010.00881.x.
Crossref Google Scholar
20

Koob GF, Buck CL, Cohen A, et al. Addiction as a stress surfeit disorder. Neuropharmacology. 2014;76:370–382. https://doi.org/10.1016/j.neuropharm.2013.05.024.
Crossref Google Scholar
21

Zorrilla EP, Koob GF. Impulsivity derived from the dark side: neurocircuits that contribute to negative urgency. Front Behav Neurosci. 2019;13:136. https://doi.org/10.3389/fnbeh.2019.00136.
Crossref Google Scholar
22

Medrano L, Flores KPE, Trógolo E, Curarello A, González J. Adaptación de la escala de Afecto Positivo y Negativo (PANAS) para la población de estudiantes universitarios de Córdoba. Ann Inv Fac Psicol. 2015;2(1):22–36.

Google Scholar
23

Cyders MA, Dzemidzic M, Eiler WJ, et al. Negative urgency and ventromedial prefrontal cortex responses to alcohol cues: FMRI evidence of emotion-based impulsivity. Alcohol Clin Exp Res. 2014;38(2):409–417. https://doi.org/10.1111/acer.12266.
Crossref Google Scholar
24
Cyders MA, Coskunpinar A, VenderVeen JD. Urgency: a common transdiagnostic endophenotype for maladaptive risk-taking. In: Zeigler-Hill V, Marcus D, eds. The Dark Side of Personality, American Psychological Association. Whashington D.C; 2016.
Crossref
25

Austin HRT, Notebaert L, Wiers RW, et al. Potions for Emotions: do self-reported individual differences in negative-emotional drinking predict alcohol consumption in the laboratory following exposure to a negative experience? Addict Behav Rep. 2019;11:100243. https://doi.org/10.1016/j.abrep.2019.100243.
Crossref Google Scholar
26

Rawls E, Wolkowicz NR, Ham LS, et al. Negative urgency as a risk factor for hazardous alcohol use: dual influences of cognitive control and reinforcement processing. Neuropsychologia. 2021;161:108009. https://doi.org/10.1016/j.neuropsychologia.2021.108009.
Crossref Google Scholar
27

Um M, Hershberger AR, Cyders MA. The relationship among depressive symptoms, urgency, and problematic alcohol and cannabis use in community adults. Addict Behav. 2019;88:36–42. https://doi.org/10.1016/j.addbeh.2018.08.009.
Crossref Google Scholar
28
Decker SE, Morie KP, Malin-Mayo B, et al. Positive and negative affect in cocaine use disorder treatment: change across time and relevance to treatment outcome. Am J Addict. 2018 Jun 20. https://doi.org/10.1111/ajad.12716. doi: 10.1111/ajad.12716. Epub ahead of print. Erratum in: Am J Addict. 2019; 28(2):132.
Crossref
29

Morgan PT, Malison RT. Pilot study of lorazepam and tiagabine effects on sleep, motor learning, and impulsivity in cocaine abstinence. Am J Drug Alcohol Abuse. 2008;34(6):692–702. https://doi.org/10.1080/00952990802308221.
Crossref Google Scholar
30

Kennedy A, Wood AE, Saxon AJ, et al. Quetiapine for the treatment of cocaine dependence: an open-label trial. J Clin Psychopharmacol. 2008;28(2):221–224. https://doi.org/10.1097/JCP.0b013e318166f50d.
Crossref Google Scholar
31

Tapp A, Wood AE, Kennedy A, et al. Quetiapine for the treatment of cocaine use disorder. Drug Alcohol Depend. 2015;149:18–24. https://doi.org/10.1016/j.drugalcdep.2014.12.037.
Crossref Google Scholar
32
Tejero A, Trujols J, Siñol N, Evaluación del craving de cocaína. In: de los Cobos JP, Instrumentos Clínicos para la evaluación de la dependencia de la cocaína. Madrid, Spain: Ars Me'dica; 2003. https://doi.org/10.15446/revfacmed.v64n4.54697.
Crossref
33

Cándido A, Orduña E, Perales JC, Verdejo-García A, Billieux J. Validación de una versión breve de la escala de comportamiento impulsivo UPPS-P. Trastor Adict. 2012;14:73–78. https://doi.org/10.1016/S1575-0973(12)70048-X.
Crossref Google Scholar
34

Hogarth L, Hardy L. Depressive statements prime goal-directed alcohol-seeking in individuals who report drinking to cope with negative affect. Psychopharmacology. 2018;235(1):269–279. https://doi.org/10.1007/s00213-017-4765-8.
Crossref Google Scholar
35

Koob GF, Volkow ND. Neurobiology of addiction: a neurocircuitry analysis. Lancet Psychiatr. 2016;3(8):760–773. https://doi.org/10.1016/S2215-0366(16)00104-8.
Crossref Google Scholar
36

Kalivas PW. The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci. 2009;10(8):561–572. https://doi.org/10.1038/nrn2515.
Crossref Google Scholar
37

Koob GF. Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement. Biol Psychiatr. 2020;87(1):44–53. https://doi.org/10.1016/j.biopsych.2019.05.023.

Crossref Google Scholar
Journal of Neurorestoratology
Volume 12 Issue 2,
June 2024
Article number: 100110
DOI: 10.1016/j.jnrt.2024.100110
Cite this article:
Vilapriño JJ, Clavel G, Silva M, et al. Negative urgency and negative affect paradigms in patients during cocaine detoxification treatment: Relationship to craving behaviour. Journal of Neurorestoratology, 2024, 12(2): 100110. https://doi.org/10.1016/j.jnrt.2024.100110

371

Views

0

Crossref

0

Web of Science

0

Scopus

Altmetrics
Received: 25 March 2023
Revised: 22 January 2024
Accepted: 24 January 2024
Published: 12 March 2024
© 2024 The Authors.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Return